Acquired partial lipodystrophy in an 11-year-old girl

Pediatrics International

Volumn 50, Issue 5, 2008, Pages 714-716

  Oswiecimska, Joanna ^a   Ziora, Katarzyna ^a   Geisler, Gabriela ^a   Dyduch, Antoni ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acquired partial lipodystrophy; Barraquer Simons syndrome; C3 nephritic factor; Interleukin 6; Tumor necrosis factor

Indexed keywords

ACQUIRED PARTIAL LIPODYSTROPHY; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LIPODYSTROPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; THYROID FUNCTION TEST; WEIGHT REDUCTION;

CHILD; COMPLEMENT C3; FEMALE; HUMANS; LIPODYSTROPHY;

EID: 52449133411     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02713.x     Document Type: Article

References (10)

1. Garg A. Lipodystrophies. Am. J. Med. 2000 108 : 143 52.
2. Misra A, Peethambaram A, Garg A. Clinical features and metabolic and acute derangements in acquired partial lipodystrophy: Report of 35 cases and review of literature. Medicine 2004 83 : 18 34.
3. Gurbuz O, Yucelten D, Ergun T, Khalilazer R. Partial lipodystrophy. Int. J. Dermatol. 1995 34 : 36 7.
4. Porter WM, O'Gorman-Lalor O, Lane RJM, Francis N, Bunker CB. Barraquer-Simons lipodystrophy, Raynaud's phenomenon and cutaneous vasculitis. Clin. Exp. Dermatol. 2000 25 : 277 80.
5. Mathieson PW, Peters DK. Lipodystrophy in MCGN type II: The clue to links between adipocyte and the complement system. Nephrol. Dial. Transplant. 1997 12 : 1804 6.
6. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993 259 : 87 91.
7. van Hall G, Steensberg A, Sacchetti M et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 2003 88 : 3005 10.
8. Walker UA, Kirschfink M, Peter HH. Improvement of acquired partial lipodystrophy with rosglitazone despite ongoing complement activation. Rheumatology 2003 42 : 393 4.
9. Mager DR, Roberts EA. Nonalcoholic fatty liver disease in children. Clin. Liver. Dis. 2006 10 : 109 31.
10. Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A. Proinflammatory cytokines in inactive lupus erythematosus patients. Przegl. Lek. 2005 62 : 838 42.